RAC (Regulatory Affairs Certification): Requirements, Exams, Costs, and Professional Meaning

1. What Is RAC?

RAC stands for Regulatory Affairs Certification, a professional certification for experienced practitioners working with healthcare-product regulation. The program is housed within RAPS Institute, an affiliate of the Regulatory Affairs Professionals Society (RAPS). This profile covers the credential family’s two current specialties: RAC-Drugs, for pharmaceuticals, and RAC-Devices, for medical devices. Each requires its own examination.

The credential recognizes regulatory knowledge and its application across product development, authorization, and ongoing compliance. Candidates must satisfy an education-and-experience route, pass the relevant examination, and subsequently meet recertification requirements. It is not a course-completion certificate or a government-issued professional license.

For hiring purposes, RAC should be interpreted as evidence of assessed regulatory knowledge supported by qualifying experience. It does not, by itself, establish that someone has led a successful submission, managed an inspection, or delivered a complex regulatory transformation.

2. RAC at a Glance

Full name: Regulatory Affairs Certification.

Abbreviation: RAC; current specialty designations are RAC-Drugs and RAC-Devices.

Credential type: Professional certification family.

Awarding organization: RAPS Institute, affiliated with RAPS.

Official website: RAPS Regulatory Affairs Certification

First introduced: 1991; product-specific examinations followed in 2019.

Current status: Active. Earlier geographic designations remain maintainable but are closed to new applicants.

Professional focus: Healthcare-product regulatory affairs.

Intended career stage: Experienced practitioners rather than entry-level candidates.

Geographic scope: International, with US, European, and global regulatory content.

Main eligibility requirement: Bachelor’s degree plus three relevant years, master’s plus two, doctorate plus one, or ten relevant years without a degree.

Assessment: One specialty examination, comprising 120 multiple-choice questions in 150 minutes.

Indicative initial cost: In 2026, US$605 for existing RAPS members or US$760 for nonmembers, per examination.

Maintenance: 36 development credits and recertification every three years.

Verification: RAPS credential-holder directory, issuer confirmation, and official digital badge.

3. Who Awards and Oversees the Credential?

RAPS Institute provides organizational oversight of the credential program. Its board establishes policy and strategic direction. The Regulatory Affairs Certification Board (RACB) oversees the RAC program, while examination committees of practicing regulatory specialists develop content using job-analysis studies and examination-development methods.

Pearson delivers the computer-based examinations through testing centers and online proctoring. It is the testing provider, not the credential owner. RAPS handles applications and certification administration; the RACB considers examination appeals.

RAC-Drugs and RAC-Devices have National Commission for Certifying Agencies (NCCA) accreditation. This evaluates the certification programs against credentialing standards. It is not FDA approval of a holder, accreditation of the holder’s employer, or authorization to perform a regulated professional activity.

4. When and Why Was the Credential Created?

RAC was introduced in 1991 as a professional credential for healthcare-product regulatory practitioners. Its enduring purpose is to assess professional knowledge beyond academic education and provide a recognizable qualification within a specialized occupation.

Four milestones explain the program today:

• 1991: Introduction of the original RAC designation.
• 2019: Introduction of the Drugs and Devices examinations, shifting the program toward product specialties rather than geographic examinations.
• 2022: RAPS announced NCCA accreditation of both product-specific credentials.
• Spring 2026: Revised examinations launched with updated content organization, 120 questions, and a 150-minute time limit.

Earlier versions covered the United States, Europe, Canada, and global regulation. Those examinations are no longer available to new candidates, but their holders can continue recertifying. A legacy RAC designation therefore should not automatically be treated as expired or converted into a newer product specialty.

5. Who Pursues the Credential, and Where Is It Used?

RAPS positions RAC for experienced professionals in manufacturers, regulatory agencies, consultancies, and other organizations involved in healthcare-product regulation. Typical settings include pharmaceuticals, biotechnology, medical devices, diagnostics, and businesses supporting product development and commercialization.

Relevant work includes regulatory strategy, submission planning, agency interactions, product-change assessment, regulatory operations, and postmarket compliance. Employer usage is visible in specific recruitment requirements: AbbVie has listed RAC as preferred for regulatory information-management and strategic-planning positions, alongside separate education, experience, and leadership requirements. These are examples of employer preference, not proof that the entire profession requires RAC.

For consulting assignments, the knowledge can be relevant to FDA, GMP, and GCP compliance, particularly when translating regulatory requirements into development, manufacturing, or clinical-process obligations. This is an application of the assessed subject matter, not evidence that every holder can independently lead a compliance remediation.

Professionals may pursue RAC to document breadth beyond their immediate job, prepare for broader responsibilities, or strengthen their candidacy where employers value it. The practical decision should start with the intended role: a credential cannot substitute for experience with the product type, authorities, and development stage that the assignment requires.

6. What Knowledge and Skills Does It Cover?

The specialties have different examination outlines. RAPS describes the regulatory coverage as approximately 30% US requirements, 30% European requirements, and 40% global regulatory practice. The domain weights below are approximate, not promises about an individual examination form.

RAC-Drugs

• Regulatory intelligence and research, 27%: Interpreting requirements, comparing pathways, evaluating regulatory precedents, and identifying appropriate authorities.
• Submissions, 27%: Determining dossier requirements, coordinating submission content, and maintaining regulatory obligations throughout the lifecycle.
• Collaboration, 13%: Advising development teams, addressing regulatory risk, and working with quality, clinical, and legal colleagues.
• Strategy, 22%: Assessing evidence gaps and benefit-risk issues, preparing authority interactions, and addressing postmarketing commitments.
• Project management, 11%: Managing regulatory schedules, procedures, tracking systems, and external contributors.

RAC-Devices

• Strategic planning, 27%: Evaluating device categories, claims, comparable products, commercialization pathways, and early agency engagement.
• Design and development, 27%: Reviewing testing approaches, verification and validation, product risks, documentation, and quality-system support.
• Process for licensing, registration, and renewals, 23%: Coordinating filings, responding to deficiencies, and maintaining authorization records.
• Post-market activities, 23%: Assessing changes, reporting obligations, labeling implications, and continuing regulatory compliance.

Applied capabilities

Illustrative applications include comparing development pathways for a pharmaceutical program, assessing whether a device modification affects its authorization, or translating a regulatory change into required updates to procedures and submission plans. These examples follow the examination frameworks; they are not demonstrations that every holder has performed those tasks.

Boundaries

For staffing purposes, assess scientific depth, therapeutic-area expertise, statistical interpretation, quality auditing, and regulatory-system proficiency separately. Knowledge of submission requirements is not the same as having authored a dossier, negotiated an agency response, or configured a regulatory information-management platform.

7. What Are the Eligibility Requirements?

The 2026 requirements provide four routes to either RAC examination:

• Baccalaureate or equivalent first university degree: At least three years of regulatory or regulatory-related work.
• Master’s degree: At least two years of relevant work.
• Doctorate: At least one year of relevant work.
• No degree requirement: At least ten years of regulatory-related experience.

Regulatory-related work can include quality assurance, quality control, clinical research connected to healthcare-product approval, and healthcare-product project management. A regulatory-affairs job title is therefore not the only possible qualifying background. Conversely, employment somewhere in healthcare does not automatically establish relevant experience.

Candidates attest that they meet the requirements and authorize RAPS to verify their information. Applications may be audited or require additional information. Prepare a clear employment history identifying dates, responsibilities, product categories, and the connection between the work and regulatory activities. The documentation recommendation is particularly important for candidates whose experience spans several functions.

RAPS membership and purchase of RAPS preparation materials are not prerequisites. There is no requirement to earn the other RAC specialty first. Candidates must accept examination and certification policies and acknowledge the ethics requirements.

Meeting an eligibility route allows an application for assessment. It does not confer the credential, waive the examination, or authorize the applicant to use RAC letters.

8. How Do You Earn the Credential?

Choose the specialty and submit the application

Select RAC-Drugs or RAC-Devices according to the work you intend to demonstrate. Submit the online application and payment for a testing window. Use the name appearing on your government-issued identification and an email address you will retain throughout the process. An application acknowledgment is not an examination result or certification award.

Complete review and schedule testing

RAPS may request additional eligibility information. Once authorized, candidates receive an Authorization to Test from Pearson and schedule either a testing-center appointment or an online-proctored examination. Accommodation requests require supporting documentation and should accompany the application. Online candidates must meet the testing provider’s environment and equipment requirements.

Take the examination

Both 2026 specialty examinations contain 120 multiple-choice questions with a 150-minute limit. They are administered in English and are closed-book. Questions test recall, application, and analysis. Scenario-based items assess judgment within a written problem, but the assessment does not involve submitting a workplace portfolio or being observed managing a real regulatory project.

Receive results and the award

Results are not immediate. RAPS reviews examination statistics after the testing window closes. Its process guidance allows approximately eight to sixteen weeks for emailed results. Scores use a 0-to-550 scale; they are not percentages and cannot be converted directly into numbers of correct answers.

A successful candidate may use the specialty designation once the credential has been awarded and receives access to an official digital badge. Completing a preparation course or obtaining a passing practice-test score does not satisfy this requirement.

If another attempt is necessary

Unsuccessful candidates may apply for a subsequent testing window, but not retake the examination within the same window. A new application is required. The candidate guides do not limit the number of attempts. Treat postponing an examination, rescheduling an appointment, and retaking after failure as different processes with different financial consequences.

9. How Long Does It Take, and How Do Candidates Prepare?

Prerequisite-building time: The required experience is separate from study time. An advanced degree reduces the minimum experience period but does not eliminate it. Candidates should establish eligibility before organizing a preparation schedule.

Preparation time: RAPS reports that holders commonly spend several months preparing, with its preparation page describing a self-reported average of six months. This is not a required duration or a validated study-hour prescription. Preparation needs depend on how much of the outline falls outside the candidate’s normal responsibilities.

Preparation resources: RAPS provides study checklists, reference publications, practice examinations, flashcards, courses, and preparation packages. Purchasing them is optional and does not confer preferential treatment.

Preparation choices: Use the current outline to identify weak areas, distinguish binding requirements from guidance, and practice explaining the reasoning behind regulatory decisions. Memorizing terminology alone is a poor substitute for understanding how requirements affect evidence, timing, and product changes.

Administrative time: Allow for the application deadline, appointment availability, and post-window scoring. The examination date is not the date on which certification can necessarily be claimed.

10. How Much Does the Credential Cost?

For the 2026 examination schedule, RAPS publishes the following prices in US dollars for either specialty:

• Existing RAPS member: US$605 per examination.
• Nonmember: US$760 per examination.
• Transfer after the free-transfer deadline: US$285.
• Administrative fee for an eligible withdrawal: US$100.

The withdrawal charge is not an automatic US$100 surcharge on every initial application. The candidate guide also lists a US$50 form-change fee. Confirm the applicable process before changing an examination purchase.

Illustrative first-attempt budget: A nonmember taking one specialty without paid preparation or changes should budget US$760 in examination charges. An existing member pays US$605. Someone joining specifically for the examination must add membership dues, so the member examination price is not that person’s complete cost. Travel, preparation products, applicable taxes, and currency-conversion charges are excluded.

Optional preparation: Books, practice examinations, courses, and toolboxes are separate purchases. Budget another examination application for a retake rather than assuming a free second attempt.

Ongoing costs: As of September 2026, the live recertification schedule lists US$190 for members and US$305 for nonmembers every three years. Late fees add US$155 or US$255 respectively. Development activities can create additional costs. Older recertification handbooks contain different prices, so those historical amounts should not be used for current budgeting.

11. How Do Holders Maintain the Credential?

RAC holders must earn 36 professional-development credits during each three-year cycle, submit recertification, and pay the applicable fee. Qualifying activities include education, speaking, publishing, and relevant professional service. Activities need not be sponsored by RAPS. Credits are subject to the program’s activity-specific rules rather than simply counting every hour worked.

Maintain supporting records because applications can be audited. RAPS advises retaining evidence for at least twelve months after recertification. Holders with multiple RAC credentials submit one recertification application with 36 credits, rather than accumulating 36 credits separately for every RAC specialty.

The ethics framework addresses competence, objectivity, integrity, confidentiality, honesty, and clear communication of regulatory risk. It does not replace an employer’s ethics rules or applicable professional obligations.

Failure to recertify can result in revocation and removal from the holder directory. Reinstatement is available within one year of expiration if the relevant requirements and fees are satisfied; after that period, an RAC examination must be retaken. A limited waiver process exists for specified circumstances, including serious illness or absence from paid regulatory work.

Retired practitioners over age 60 may apply for RAC Emeritus before expiration. This is a separate approved status, not permission to present a lapsed active credential as current.

12. What Is Its Professional Value, and What Are Its Limitations?

RAC’s professional value rests on a combination of relevant experience, standardized assessment, and continuing-development obligations. Its usefulness is clearest when those elements match the employer’s work. A credential in the right specialty can support an initial assessment of regulatory breadth, but should not replace evaluation of actual delivery.

Employer recognition is demonstrable but selective. AbbVie’s regulatory submission-management postings have treated RAC as an additional positive qualification while separately requiring pharmaceutical-industry experience, submission-publishing skills, and project-management capability. That distinction illustrates how the credential functions in practice: it can strengthen a candidate’s evidence without satisfying the entire role specification.

For a professional considering RAC, the likely value is greater when target roles explicitly recognize it, the examination fills meaningful knowledge gaps, and the candidate already has experience to which the learning can be applied. Its value may be lower when the immediate need is basic regulatory education or deep expertise in one unfamiliar jurisdiction.

For employers, avoid treating current status as proof of current mastery of every regulation. Recertification documents professional development, not a recurring examination of every new requirement. Likewise, do not infer a salary premium, promotion probability, or ability to secure product approval from the letters alone.

A useful evaluation separates three questions: whether the credential is genuine and active, whether its specialty fits the assignment, and whether the person has delivered comparable work.

13. What Should Employers and Clients Infer From It?

What it establishes

A current holder has met a qualifying experience route, passed the relevant examination, accepted program obligations, and maintained status when renewal became due. The experience route may include regulatory-related work rather than exclusively regulatory-affairs employment.

What still requires evaluation

Assess product and jurisdiction experience, personal contribution to submissions, scientific judgment, leadership, communication, and delivery under pressure. Ask whether the person owned decisions or supported someone else’s work. An individual RAC does not establish that a consulting firm is accredited or that a manufacturer’s products or facilities are authorized.

Where it can inform staffing

The assessed knowledge suggests relevance to submission workstreams, lifecycle-change reviews, regulatory operating-model projects, and regulatory impact assessment for pharmaceutical or medical-device businesses. This is a staffing inference from the content, not a claim that the credential alone qualifies someone to lead those assignments.

Evidence to request

Request redacted strategy documents, submission responsibility summaries, change-assessment examples, risk registers, or references from comparable projects. Protect confidential product information and distinguish team results from the candidate’s personal contribution.

Three questions to assess applied competence

1. For a product in your RAC specialty, how did you compare plausible regulatory pathways and decide what evidence was missing? A useful answer connects product characteristics, intended claims, jurisdiction, evidence gaps, and decision criteria.
2. Describe a postauthorization product or manufacturing change you assessed: how did you determine its regulatory consequences? Look for a documented rationale, affected markets, reporting or submission implications, and coordination with quality and technical teams.
3. When commercial timing conflicted with a regulatory concern, how did you present options and escalate the decision? A strong answer distinguishes legal requirements from preferences, communicates uncertainty, and preserves an auditable decision record.

14. How Does It Compare With Related Credentials?

RCC-MDR: The Regulatory Compliance Certification focused on the EU Medical Device Regulation is narrower than RAC-Devices. It suits practitioners needing concentrated knowledge of that framework. Eligibility combines a relevant degree with one year of device-related regulatory experience, or four years of relevant experience without that degree route. It requires a separate examination and can complement RAC-Devices.

RCC-IVDR: This counterpart focuses on the EU In Vitro Diagnostic Medical Devices Regulation. Its experience must relate to diagnostics: a relevant degree plus one year, or four years of relevant experience. It is an alternative for a narrowly focused assessment or a complement to broader device-regulatory knowledge, not an automatic progression from RAC.

Foundation in Regulatory Affairs (FRA): RAPS offers this family of assessment-based certificates for foundational learning, including introductory and global-strategy options for drugs and devices. No experience prerequisites are needed to sit the examinations. FRA emphasizes basic knowledge rather than RAC’s experienced-practitioner assessment and does not confer RAC letters. It may precede RAC educationally, but is not a mandatory prerequisite.

RAPS Regulatory Affairs Certificate programs: These are educational programs in pharmaceuticals, devices, or both. Completion documents participation in structured learning; it is not equivalent to satisfying RAC experience requirements and passing its independent certification examination. The similar names make this distinction particularly important when reviewing résumés.

Choose among these according to the evidence needed: foundational learning, specialized EU knowledge, or broader experienced-practitioner regulatory assessment.

15. How Can You Verify the Credential and Use Its Letters Correctly?

Start with the RAPS Institute credential-holder directory. Obtain the person’s full name, claimed specialty or legacy designation, and current status information. The directory includes current product specialties and earlier RAC designations. Match the individual carefully rather than relying on a similar name.

Ask the holder to share their official digital badge and inspect its credential record, rather than accepting a screenshot as conclusive evidence. RAPS uses BadgeCert for its badges. If the directory and supplied evidence do not resolve the claim, request confirmation through the RAPS Program Office with the holder’s cooperation.

A missing public listing is not conclusive proof of misrepresentation. RAPS allows holders to opt out of public listing, and newly awarded credentials may require time to appear. Verification should distinguish original achievement from present good standing.

Current product-specialty holders may use RAC-Drugs or RAC-Devices after their names. Applicants and preparation-course participants may not claim an unearned designation. Holders who fail to recertify cannot continue using the active designation.

For legacy holders, retain the actual credential identity rather than assuming conversion to a newer specialty. An approved retired holder uses “RAC Emeritus,” which should not be presented as active certification for employment advertising.

16. Frequently Asked Questions

Can I earn RAC without a university degree?

Yes. The current requirements include a route based on at least ten years of regulatory-related experience regardless of formal degree. This is an experience-based eligibility route, not an exemption from the specialty examination or later maintenance obligations.

Can quality or clinical-research experience count?

Potentially. RAPS includes quality assurance, quality control, clinical research related to healthcare-product approval, and healthcare-product project management within its examples. Evaluate the actual work and its regulatory relevance rather than assuming that a department name establishes eligibility.

Do I need both RAC-Drugs and RAC-Devices?

No. They are separate specialties, and candidates may pursue one or both. Select the examination matching your responsibilities. Holding both may be useful for cross-product work, but does not remove the need to evaluate experience with particular technologies or combination products.

Does the 2026 examination change invalidate an older RAC?

No. The revision applies to the examination, not automatic cancellation of existing credentials. Current holders continue under the recertification framework. Earlier geographic credentials also remain recognized when properly maintained, despite those examinations being closed to new applicants.

Does holding two RAC specialties double the renewal credits?

No. RAPS requires one recertification application containing 36 credits for holders of multiple RAC credentials. Confirm the expiration date recorded in your account, especially after earning another specialty, rather than assuming each credential has an independent credit requirement.

17. Official Resources and Recent Changes

Official resources available: RAPS provides specialty candidate guides, examination outlines, study checklists, preparation materials, ethics requirements, recertification guidance, process FAQs, and credential-verification resources. Candidates should use materials for their examination year and specialty.

Material examination change: Beginning with the spring 2026 window, both examinations increased from 100 to 120 questions and from two hours to two and a half hours. Domain names and weights also changed. Older descriptions of a two-hour examination are therefore historical.

Current scheduling: The autumn 2026 testing window runs from November 2 through December 4, 2026. Its application deadline was September 24, 2026.

This profile is an independent Umbrex reference and is not issued or endorsed by the credential owner unless an explicit relationship is stated.